PL2730279T3 - Preparaty cynakalcetu o natychmiastowym uwalnianiu - Google Patents

Preparaty cynakalcetu o natychmiastowym uwalnianiu

Info

Publication number
PL2730279T3
PL2730279T3 PL12007638T PL12007638T PL2730279T3 PL 2730279 T3 PL2730279 T3 PL 2730279T3 PL 12007638 T PL12007638 T PL 12007638T PL 12007638 T PL12007638 T PL 12007638T PL 2730279 T3 PL2730279 T3 PL 2730279T3
Authority
PL
Poland
Prior art keywords
cinacalcet
immediate release
release formulations
formulations
immediate
Prior art date
Application number
PL12007638T
Other languages
English (en)
Inventor
Silva Gabriel Leitão
Stephanie Cadonau
Simões Sérgio Paulo
Christian Drescher
Original Assignee
K H S Pharma Holding Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47189684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2730279(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by K H S Pharma Holding Gmbh filed Critical K H S Pharma Holding Gmbh
Publication of PL2730279T3 publication Critical patent/PL2730279T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
PL12007638T 2012-11-09 2012-11-09 Preparaty cynakalcetu o natychmiastowym uwalnianiu PL2730279T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12007638.5A EP2730279B1 (en) 2012-11-09 2012-11-09 Immediate release formulations of cinacalcet

Publications (1)

Publication Number Publication Date
PL2730279T3 true PL2730279T3 (pl) 2015-12-31

Family

ID=47189684

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12007638T PL2730279T3 (pl) 2012-11-09 2012-11-09 Preparaty cynakalcetu o natychmiastowym uwalnianiu

Country Status (6)

Country Link
US (1) US20150306049A1 (pl)
EP (1) EP2730279B1 (pl)
DK (1) DK2730279T3 (pl)
ES (1) ES2547577T3 (pl)
PL (1) PL2730279T3 (pl)
WO (1) WO2014072346A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019186516A1 (en) 2018-03-30 2019-10-03 Ftf Pharma Private Limited Liquid dosage forms of cinacalcet or salt thereof
CN112546010A (zh) * 2020-12-02 2021-03-26 普莱赛思(天津)生命科技有限公司 一种肾病药物组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122005000033I1 (de) 1994-10-21 2005-09-29 Nps Pharma Inc Kalzium-Rezeptor aktive Verbindungen.
DK2821067T3 (en) * 2003-09-12 2017-12-04 Amgen Inc Quick solution formulation of cinacalcet
WO2007062147A1 (en) 2005-11-22 2007-05-31 Teva Pharmaceutical Industries Ltd. Crystal forms of cinacalcet hci and processes for their preparation
BRPI0715635A2 (pt) * 2006-09-01 2013-07-02 Teva Pharma compàsitos sàlidos de um composto de cÁlcio receptor-ativo
WO2008064202A2 (en) 2006-11-20 2008-05-29 Dr. Reddy's Labortories, Ltd. Modified-release formulations of calcium receptor-active compounds
US20090275780A1 (en) 2008-05-05 2009-11-05 Medichem, S.A. Process for controlling the particle size of a 3-(trifluoromethyl)phenyl]-1-aminopropane derivative
JP2012503613A (ja) 2008-09-25 2012-02-09 ラシオファルム ゲーエムベーハー コンパクト化シナカルセット
DK2642980T3 (da) 2010-11-23 2020-06-22 Amgen Inc Pædiatrisk formulering

Also Published As

Publication number Publication date
US20150306049A1 (en) 2015-10-29
EP2730279A1 (en) 2014-05-14
EP2730279B1 (en) 2015-07-22
DK2730279T3 (en) 2015-10-26
WO2014072346A1 (en) 2014-05-15
ES2547577T3 (es) 2015-10-07

Similar Documents

Publication Publication Date Title
ES2892029T5 (en) Formulations of enzalutamide
IL234256B (en) Tamper resistant immediate release formulations
ZA201503603B (en) Composition for immediate and extended release
IL236304A0 (en) Formulations for diclofenac
SI2827862T1 (sl) Formulacije bendamustina
EP4342536C0 (en) BROMOCRIPTINE FORMULATIONS
ZA201406082B (en) Use of ccr3-inhibitors
ZA201409259B (en) Insecticidal formulations of microcapsules
AP3681A (en) Modified release formulations for oprozomib
SMT201700574T1 (it) Formulazioni delle combinazioni di darunavir
PL2753311T3 (pl) Preparaty antyoksydacyjne
GB201501016D0 (en) Preparation of 18F-fluciclovine
LT2623096T (lt) Farmacinė lėto atpalaidavimo trimetazidino kompozicija
ZA201308316B (en) Sustained release paracetamol formulations
EP2867199A4 (en) STABLE COMPOSITIONS OF ESOTRERODINE
GB201210530D0 (en) Extended release formulations
PL2730279T3 (pl) Preparaty cynakalcetu o natychmiastowym uwalnianiu
SG11201404915SA (en) Sustained release oral solid preparation
GB201206178D0 (en) Formulations